Clinical Trial Update: Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury [Phase 1]

View source ↗

Summary

Phase 1 safety study of nebulized sodium nitroprusside in adults with acute lung injury or acute respiratory distress syndrome; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Sodium nitroprusside (sodium nitroprusside)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 1 | Status: UNKNOWN